Collegium

Not verified. Claim this page

Sustainability Summary

  • This is an unclaimed profile. Collegium has not joined Sustainability Tracker to verify their sustainability credentials. We gathered what we could from public sources.
Powered by Tracker AI BETA; there may be errors

Collegium Sustainability Profile

Collegium is not currently tracking sustainability.

Sustainability Summary

  • This is an unclaimed profile. Collegium has not joined Sustainability Tracker to verify their sustainability credentials. We gathered what we could from public sources.
Powered by Tracker AI BETA; there may be errors
Collegium Pharmaceutical, Inc. is a pharmaceutical company that, in its 2026 proxy statement, said it emphasizes ESG initiatives, employee development, and culture. The filing notes that the company published its fourth annual ESG report in February 2026 on its corporate website, highlighting ESG accomplishments. The available content focuses mainly on governance and reporting rather than environmental or social programs, and it does not provide detailed sustainability targets. No explicit sustainability partnerships or product sustainability claims are identified in the source material.

Collegium Sustainability Actions

Published fourth ESG report

In February 2026, we published our fourth annual ESG report on our corporate website highlighting our ESG accomplishments.

Emphasized ESG initiatives

The proxy highlights ... and emphasizes ESG initiatives, employee development, and culture.

Strong board independence

The company reports strong governance with seven of eight independent directors.

See All (4)